Moderna vaccine gets DGCI emergency use approval
American vaccine company ‘Moderna’ has received emergency use approval from DCGI. This information was given by Dr. VK Paul, Member (Health) of NITI Aayog during the press conference. Dr Paul said that after the arrival of Moderna, there are now a total of four vaccines in the country. Covaxin, Covishield, Sputnik have already been approved in India.
Apart from this, DCGI has allowed drug manufacturer Cipla to import Moderna Vaccine in India. Cipla had sought permission to import and market the US vaccine in India a day earlier.
Moderna’s vaccine relies on RNA
Moderna’s vaccine relies on messenger RNA, which programs cells to develop immunity against the coronavirus. The results of clinical trials conducted regarding this vaccine show that this vaccine is more than 90 percent effective against cases with symptoms of corona infection. Apart from this, the head of the National Task Force, VK Paul has also said that the government is constantly in touch with foreign vaccine manufacturers.
